retatrutide clinical trial texas Michael Weintraub, MD on X: "Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its Demand for Unapproved Weight-Loss Drug

P.HallidayG

Foundayo is a once-daily pill classified as an oral small-molecule GLP-1 receptor agonist, with a different chemical structure from injectable GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), and from oral semaglutide (Rybelsus, the Wegovy pill), which belongs to the same peptide class as the injectables

Pregnant or nursing women: Safety hasn't been established

Semaglutide is the top driver for prescription demand both in hospitals and retail pharmacies

How GLP-1 medications affect your levothyroxine This is where practical concerns get very real for Hashimoto's patients

Reevaluation of glucose-dependent insulinotropic polypeptide (GIP) pharmacology in combination with glucagon-like peptide-1 (GLP-1) for metabolic diseases: Overview on biological GIP and GLP-1 effects at the organ/tissue level